Financials

News Discussions Technicals Seasonals

8YY fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to BIOLIDICS operating, investing, and financing activities

8YY free cash flow for Q4 24 is -777 k SGD. For 2024, 8YY free cash flow was -2.32 M SGD and operating cash flow was -2.31 M SGD.

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: SGD

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—